Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease. Drugs in this group aim to slow disease progression and manage symptoms. Pirfenidone and nintedanib are two examples that have been approved to treat IPF.
Products of Idiopathic pulmonary fibrosis (IPF) treatment
